<i id='FC7DE9A928'><strike id='FC7DE9A928'><tt id='FC7DE9A928'><pre id='FC7DE9A928'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
ChatGPT in medicine: STAT answers readers' burning questions 
Why health workers in Gaza are injured or die at high rates
Trump demands the U.S. pay no more for drugs than other countries … again 
UnitedHealth financials solid despite Change Healthcare cyberattack 
How one medical school became remarkably diverse 
Dogs on Prozac: What pet anti 
New air purifier tech could be key to improving indoor air quality 
HHS leader on health, climate change and biopharma emissions 
How to save PrEP access — and even expand it 
STAT Summit: Biotech founders on deal 
Medicare details structure of new drug price negotiation program 
Key Senate committee drafts bipartisan bill to stem drug shortages
How to save PrEP access — and even expand it 
After traumatic brain injury, life support decisions can use more time 
Apple is now the first public company to be valued at $3 trillion 
